The largest database of trusted experimental protocols

T7 polymerase mmessage mmachine kit

Manufactured by Thermo Fisher Scientific
Sourced in United States

The T7 polymerase mMessage mMachine kit is a laboratory product designed for the in vitro transcription of mRNA. It utilizes the T7 RNA polymerase enzyme to produce capped and polyadenylated mRNA from DNA templates.

Automatically generated - may contain errors

11 protocols using t7 polymerase mmessage mmachine kit

1

Heterozygous KCNQ1 V141M Mutation Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Xenopus oocytes that expressed human wild type (WT) KCNQ1 or V141M KCNQ1 and WT KCNE1 were used to record WT IKCNQ1+KCNE1 (WT IKs) and V141M IKCNQ1+KCNE1 (V141M IKs). KCNQ1 (provided by S. Goldstein, University of Chicago, Chicago, IL) and KCNE1 (provided by S. Nakanishi, Osaka Bioscience Institute, Osaka, Japan) were subcloned into the HindIII/XbaI cloning sites of pcDNA3.1+ vectors (Invitrogen, Grand Island, NY). The V141M KCNQ1 mutation was generated by using overlap extension amplification with high-fidelity polymerase chain reaction (PCR), verified by DNA sequencing (IDT technology, Coralville, IW). Messenger RNA was transcribed in vitro using the mMessage mMachine T7 polymerase kit (Applied Biosystems, Oyster Bay, NY). The follicle layer of oocytes was digested using type 1A collagenase (Sigma-Aldrich, Saint Louis, MO). Stage IV–V Xenopus oocytes were selected and injected with 4.6 ng mRNA per oocyte. For implementing a heterozygous genotype, we expressed heterozygous V141M IKs channels in oocytes that RNAs of WT KCNQ1 and V141M KCNQ1 at 1:1 ratio were injected. Total KCNQ1 and KCNE1 injection ratios for WT and V141M were the same at 6:1. Injected oocytes were incubated in ND96 solution (in mM: 96 NaCl, 2 KCl, 1.8 CaCl2, 1 MgCl2, and 5 Hepes, pH 7.60) at 18 °C for 3–5 days before recording.
+ Open protocol
+ Expand
2

Site-Directed Mutagenesis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Site-directed mutations were introduced using overlap extension and high-fidelity PCR. DNA sequencing confirmed each mutation. RNA was made by in vitro transcription using the mMessage mMachine T7 polymerase kit (Applied Biosystems).
+ Open protocol
+ Expand
3

Heterogeneous KCNQ1/KCNE1 Channel Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols

Xenopus oocytes that expressed human wild type (WT) KCNQ1 or V141M KCNQ1 and WT KCNE1 were used to record WT IKCNQ1+KCNE1 (WT IKs) and V141M IKCNQ1+KCNE1 (V141M IKs). KCNQ1 (provided by S. Goldstein, University of Chicago, Chicago, IL) and KCNE1 (provided by S. Nakanishi, Osaka Bioscience Institute, Osaka, Japan) were subcloned into the HindIII/XbaI cloning sites of pcDNA3.1+ vectors (Invitrogen, Grand Island, NY). The V141M KCNQ1 mutation was generated by using overlap extension amplification with high-fidelity polymerase chain reaction (PCR), verified by DNA sequencing (IDT technology, Coralville, IW). Messenger RNA was transcribed in vitro using the mMessage mMachine T7 polymerase kit (Applied Biosystems, Oyster Bay, NY). The follicle layer of oocytes was digested using type 1A collagenase (Sigma-Aldrich, Saint Louis, MO). Stage IV–V Xenopus oocytes were selected and injected with 4.6 ng mRNA per oocyte. For implementing a heterozygous genotype, we expressed heterozygous V141M IKs channels in oocytes that RNAs of WT KCNQ1 and V141M KCNQ1 at 1:1 ratio were injected. Total KCNQ1 and KCNE1 injection ratios for WT and V141M were the same at 6:1. Injected oocytes were incubated in ND96 solution (in mM: 96 NaCl, 2 KCl, 1.8 CaCl2, 1 MgCl2, and 5 Hepes, pH 7.60) at 18 °C for 3–5 days before recording.
+ Open protocol
+ Expand
4

Xenopus Oocyte Kv Channel Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Complementary RNA (cRNA) transcripts encoding human KCNQ1, KCNQ2, KCNQ3, KCNE1, KCNE3, KCNE4, or SMIT1 were generated by in vitro transcription using a T7 polymerase mMessage mMachine kit (Thermo Fisher Scientific), after vector linearization, from complementary DNA (cDNA) subcloned into plasmids incorporating X. laevis β-globin 5′ and 3′ untranslated regions flanking the coding region to enhance translation and cRNA stability. cRNA was quantified by spectrophotometry. Mutant cDNAs were generated by site-directed mutagenesis using a QuikChange kit according to the manufacturer’s protocol (Agilent, Santa Clara, CA) and corresponding cRNAs prepared as above. Commercially sourced, defolliculated stages V and VI X. laevis oocytes (Ecocyte Bioscience, Austin, TX) were injected with Kv channel α subunit cRNAs (10 ng total per oocyte). Oocytes were incubated at 16°C in Barth’s saline solution (Ecocyte Bioscience) containing penicillin and streptomycin, with daily washing for 2 to 5 days before two-electrode voltage-clamp (TEVC) recording.
+ Open protocol
+ Expand
5

Heterologous Expression of Kv7.4 and Kv7.5

Check if the same lab product or an alternative is used in the 5 most similar protocols
cRNA transcripts encoding human Kv7.4 and Kv7.5 were generated by in vitro transcription using the T7 polymerase mMessage mMachine kit (Thermo Fisher Scientific), after vector linearization, from cDNA and sub-cloned into plasmids incorporating Xenopus laevis β-globin 5’ and 3’ UTRs flanking the coding region to enhance translation and cRNA stability. We quantified cRNA by spectrophotometry. Defolliculated stage V and VI Xenopus laevis oocytes (Xenoocyte, Dexter, MI, US) were injected with Kv7.4 and/or Kv7.5 cRNA (20 ng total per oocyte). Oocytes were incubated at 16 °C in Barth’s saline solution (Ecocyte Bioscience, Austin, TX) containing penicillin and streptomycin, and washed daily for 3–5 days prior to two-electrode voltage-clamp (TEVC) recording.
+ Open protocol
+ Expand
6

Xenopus Oocyte Expression of Ion Channels

Check if the same lab product or an alternative is used in the 5 most similar protocols
cRNA transcripts encoding human KCNQ1, TMC1 and TMC2 were generated by in vitro transcription using the T7 polymerase mMessage mMachine kit (Thermo Fisher Scientific), after vector linearization. cRNA was quantified by spectrophotometry. Defolliculated stage V and VI Xenopus laevis oocytes (Ecocyte Bioscience, Austin, TX) were injected with cRNAs (5–10 ng). The oocytes were incubated at 16 °C in Barth’s saline solution (Ecocyte) containing penicillin and streptomycin, with daily washing, for 2–12 days prior to two-electrode voltage-clamp (TEVC) recording.
+ Open protocol
+ Expand
7

Heteromeric potassium channel expression in Xenopus oocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
cRNA transcripts encoding hKv4.3L, hKv4.3S and hKChIP2b were generated by in vitro transcription (T7 polymerase mMessage mMachine kit, Thermo Fisher Scientific), after vector linearization, from cDNA sub-cloned into plasmids (a kind gift of Dr. Steve A. N. Goldstein, Brandeis University, Waltham, MA) incorporating X. laevis β-globin 5′ and 3′ UTRs flanking the coding region to enhance translation and cRNA stability. T504A and T504D Kv4.3L mutants were made using a QuikChange Site-Directed Mutagenesis kit (Agilent, Santa Clara, CA) per the manufacturer's protocol and confirmed by sequencing. Human KCNE2 and KCNE4L were also transcribed from cDNA templates incorporating X. laevis β-globin 5′ and 3′ UTRs. cRNA was quantified by spectrophotometry. Defolliculated stage V and VI X. laevis oocytes (Ecocyte Bioscience, Austin, TX) were injected with one, two or three of the subunit cRNAs as follows: 1.5 ng of Kv4.3L or Kv4.3S; with or without 5 ng of KChIP2b, with or without 5 ng of KCNEx. Oocytes were incubated at 16°C in SBB solution (Ecocyte) containing penicillin and streptomycin, with daily washing, for 2–3 days prior to two-electrode voltage-clamp (TEVC) recording.
+ Open protocol
+ Expand
8

Xenopus Oocyte Expression of KCNQ and GLRA1

Check if the same lab product or an alternative is used in the 5 most similar protocols
We generated cRNA transcripts encoding human KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5 or GLRA1 (NM_001146040) (GenScript, Piscataway, NJ, USA) by in vitro transcription using the T7 polymerase mMessage mMachine kit (Thermo Fisher Scientific), after vector linearization, from cDNA sub-cloned into plasmids incorporating Xenopus laevis β-globin 5′ and 3′ UTRs flanking the coding region to enhance translation and cRNA stability. We quantified cRNA by spectrophotometry. We generated mutant KCNQ2 and KCNQ3 cDNAs by site-directed mutagenesis using a QuikChange kit (Stratagene, San Diego, CA) and prepared the corresponding cRNAs as above. We injected defolliculated stage V and VI Xenopus laevis oocytes (Ecocyte Bioscience, Austin, TX and Xenoocyte, Dexter, MI) with KCNQ channel α subunit (5-20 ng) or GLRA1 (20 ng) cRNAs. We incubated the oocytes at 16 °C in Barth’s saline solution (Ecocyte Bioscience) containing penicillin and streptomycin, with daily washing, for 2–5 days prior to two-electrode voltage-clamp (TEVC) recording.
+ Open protocol
+ Expand
9

Transcription and Expression of Kv Channel Subunits

Check if the same lab product or an alternative is used in the 5 most similar protocols
cRNA transcripts encoding human KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5, KCNA1, or KCNE1 were generated by in vitro transcription using the T7 polymerase mMessage mMachine kit (Thermo Fisher Scientific), after vector linearization, from complementary DNA (cDNA) sub-cloned into plasmids incorporating Xenopus laevis β-globin 5′ and 3′ untranslated regions flanking the coding region to enhance translation and cRNA stability. cRNA was quantified by spectrophotometry. Mutant KCNQ3 cDNAs were generated by site-directed mutagenesis using a QuikChange kit according to manufacturer’s protocol (Stratagene, San Diego, CA) and corresponding cRNAs prepared as above. Defolliculated stage V and VI Xenopus laevis oocytes (Ecocyte Bioscience, Austin, TX) were injected with Kv channel α subunit cRNAs (5–10 ng). Oocytes were incubated at 16 °C in Barth’s saline solution (Ecocyte) containing penicillin and streptomycin, with daily washing, for 3–5 days prior to TEVC recording or 3H-GABA binding assays.
+ Open protocol
+ Expand
10

Heteromeric KCNE Subunit Expression in Xenopus Oocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
cRNA transcripts encoding hKCNE3L and hKCNE4L were generated by in vitro transcription (T7 polymerase mMessage mMachine kit, Thermo Fisher Scientific) from synthetic genes sub-cloned into pCDNA3.1+ with Xenopus laevis β-globin 5′ and 3′ UTRs flanking the coding region to enhance translation and cRNA stability, after vector linearization. hKCNE3S and hKCNE4S cRNAs were similarly generated, after using site-directed mutagenesis (Agilent, Santa Clara, CA), to disrupt the exon 1 start site on the cDNAs of their long counterparts to facilitate direct comparisons of short versus long isoforms in otherwise identical constructs. Human Kv4.2, Kv4.3 (full-length) and KChIP2 were similarly transcribed from cDNA templates also incorporating Xenopus laevis β-globin 5′ and 3′ UTRs (a kind gift of Dr. Steve A. N. Goldstein), as were human HCN1, hERG and Kv1.1. cRNA was quantified by spectrophotometry. Defolliculated stage V and VI Xenopus laevis oocytes (Ecocyte Bioscience, Austin, TX) were injected with one, two or three of the subunit cRNAs (5 ng of KCNE subunits, 4 ng hERG, 10 ng HCN1, 1–5 ng KChIP2, 0.1 ng Kv1.1, 1 ng Kv4.2, 1–5 ng Kv4.3 per oocyte). Oocytes were incubated at 16 °C in SBB solution (Ecocyte) containing penicillin and streptomycin, with daily washing, for 2–3 days before two-electrode voltage-clamp (TEVC) recording.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!